Letter to the editor
Editor, – In reference to the article 'Flying and thromboembolism' (Aust Prescr 2009;32:148-50), is there any place for rivaroxaban currently only listed for major orthopaedic surgery in high-risk long-haul flight patients? If so, at what dosage and for how long? These patients would previously have been offered subcutaneous low molecular weight heparin.
The Travel Doctor - Traveller's Medical and Vaccination Centre